GISSI-2: mortality plus extensive left-ventricular damage as "end-point".
De Vita
C
C
Franzosi
M G
MG
Geraci
E
E
Maggioni
A P
AP
Mauri
F
F
Mezzanotte
G
G
Tavazzi
L
L
Tognoni
G
G
Volpi
A
A
D000465:Algorithms; D006352:Heart Ventricles / Q000293:injuries; D006801:Humans; D007558:Italy; D009203:Myocardial Infarction / Q000188:drug therapy* / Q000401:mortality; D016032:Randomized Controlled Trials as Topic; D013300:Streptokinase / Q000627:therapeutic use*; D010959:Tissue Plasminogen Activator / Q000627:therapeutic use*
D013300:Streptokinase; D010959:Tissue Plasminogen Activator